TRIANA Biomedicines welcomes Mariya Atanasova as our Senior Scientist I, Biology & Translational Sciences! We are so glad to have you as part of Team TRIANA!
TRIANA Biomedicines
生物技术研究
Lexington,Massachusetts 3,257 位关注者
TRIANA Biomedicines rationally designs Molecular Glue for high-value disease targets.
关于我们
TRIANA Biomedicines is a venture-backed biopharmaceutical company leading a transformative approach to discover and develop novel small molecules to treat disease. Our technology enables us to identify molecules that promote the interaction between a target and another protein in a way that alters the fate or function of the target protein. These innovative “molecular glues” allow us to treat disease in entirely new ways by pursuing highly disease relevant targets that have long been considered undruggable or are inadequately addressed. Our target-first, rational approach to molecular glue discovery lets us consider a wide-range of therapeutic applications for our products. Our initial focus on targeted protein degradation is driven by our desire to discover and develop groundbreaking new cancer medicines. TRIANA Biomedicines is headquartered in Waltham, Massachusetts, and has established internal laboratory work as well as key collaborations with academia and industry partners.
- 网站
-
https://www.trianabio.com
TRIANA Biomedicines的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Lexington,Massachusetts
- 类型
- 私人持股
地点
-
主要
1050 Waltham St
Suite 301
US,Massachusetts,Lexington,02421
TRIANA Biomedicines员工
动态
-
Congratulations Patrick Trojer, PhD, Daniel La, Maolin Yu, and Alison Fox!
-
TRIANA Biomedicines welcomes John Lisher as our Senior Scientist I, Lead Discovery! We are so glad to have you as part of Team TRIANA!
-
TRIANA Biomedicines welcomes David Rhee as our Associate Director of Biology & Translational Sciences! We are so glad to have you as part of Team TRIANA!
-
TRIANA Biomedicines welcomes Rachel Badger as our Senior Research Associate, Lead Discovery! We are so glad to have you as part of Team TRIANA!
-
Congratulations Aleksandra (Sasha) Zagulyaeva, PhD and Andy S.!
-
Big news today for TRIANA! Announcing a research collaboration with Pfizer to Discover?novel molecular glue degraders https://lnkd.in/exAGkn68
-
The first exciting morning is coming to an end. The opening of the BIOTECH SUMMIT AUSTRIA 2024 was hosted by Peter Llewellyn-Davies from BIOTECH AUSTRIA, Klaus Weinberger from Health Hub Tirol and Lejla Pock from Human.technology Styria GmbH. The event kicked off with an engaging presentation on the topic "Seed and succeed – how to build a multibillion dollar biotech – and exit!" Thank you, Patrick Trojer, from TRIANA Biomedicines, for the valuable insights into the subject. The day continued with a panel specializing in upcoming trends in the biotech sector. A big thank you to Doris Wilflingseder, Guido Gualdoni, Herbert Tilg, Ralf Huss and Sophie Zettl for sharing future trends and contributing to the valuable discussion. In cooperation with: Standortagentur Tirol, Human.technology Styria GmbH #BSA24 #trends #future #panels?#biotech #technology
-
TRIANA Biomedicines welcomes Louis Plamondon, Ph.D. as our Executive Vice President, Head of Pharmaceutical Development! We are so glad to have you as part of Team TRIANA!
-
Check out these exciting new roles at TRIANA Biomedicines! Visit the Careers Page on our website to learn more about joining Team TRIANA! https://lnkd.in/dRUZDvwb